(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL4A2 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of COL4A2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of COL4A2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:1308085 6480464 1-Naphthylisothiocyanate results in increased expression of COL4A2 mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of COL4A2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL4A2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1317652 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of COL4A2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL4A2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1308085 6480464 Tetrachlorodibenzodioxin results in decreased expression of COL4A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1308085 6480464 Tetrachlorodibenzodioxin results in increased expression of COL4A2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of COL4A2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of COL4A2 mRNA CTD PMID:24035824 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of COL4A2 mRNA CTD PMID:21570461 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL4A2 mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of COL4A2 mRNA CTD PMID:18200517 2-methylcholine affects expression ISO RGD:1317652 6480464 beta-methylcholine affects the expression of COL4A2 mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane increases expression ISO RGD:1308085 6480464 4, 4'-diaminodiphenylmethane results in increased expression of COL4A2 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL4A2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1317652 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL4A2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of COL4A2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of COL4A2 exon CTD PMID:33297965 5-fluorouracil affects response to substance ISO RGD:1317652 6480464 COL4A2 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:1317652 6480464 Fluorouracil results in decreased expression of COL4A2 protein CTD PMID:15352031 6-propyl-2-thiouracil increases expression ISO RGD:1308085 6480464 Propylthiouracil results in increased expression of COL4A2 mRNA CTD PMID:30047161 8'-apo-beta,psi-caroten-8'-al decreases expression ISO RGD:1317652 6480464 apocarotenal results in decreased expression of COL4A2 mRNA CTD PMID:17034753 9-cis-retinoic acid increases expression ISO RGD:1317652 6480464 Alitretinoin results in increased expression of COL4A2 mRNA CTD PMID:17034753 acrylamide decreases expression ISO RGD:1317652 6480464 Acrylamide results in decreased expression of COL4A2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1317652 6480464 Aflatoxin B1 affects the expression of COL4A2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1317652 6480464 Aflatoxin B1 results in increased methylation of COL4A2 exon CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:1317652 6480464 Aflatoxin B1 results in decreased methylation of COL4A2 gene, Aflatoxin B1 results in decreased methylation of COL4A2 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of COL4A2 mRNA CTD PMID:19770486 Aflatoxin B2 alpha decreases methylation ISO RGD:1317652 6480464 aflatoxin B2 results in decreased methylation of COL4A2 intron CTD PMID:30157460 aldehydo-D-glucose affects secretion ISO RGD:1317652 6480464 Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 all-trans-4-oxoretinoic acid increases expression ISO RGD:1317652 6480464 4-oxoretinoic acid results in increased expression of COL4A2 mRNA CTD PMID:17034753 all-trans-4-oxoretinol increases expression ISO RGD:1317652 6480464 4-oxoretinol results in increased expression of COL4A2 mRNA CTD PMID:17034753 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of COL4A2 mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of COL4A2 mRNA CTD PMID:30951980 all-trans-retinoic acid decreases expression ISO RGD:1317652 6480464 Tretinoin results in decreased expression of COL4A2 mRNA CTD PMID:12875902 , PMID:23724009 all-trans-retinoic acid increases expression ISO RGD:1317652 6480464 Tretinoin results in increased expression of COL4A2 mRNA CTD PMID:17034753 all-trans-retinol increases expression ISO RGD:1317652 6480464 Vitamin A results in increased expression of COL4A2 mRNA CTD PMID:17034753 amitrole increases expression ISO RGD:1308085 6480464 Amitrole results in increased expression of COL4A2 mRNA CTD PMID:30047161 ammonium chloride affects expression ISO RGD:1308085 6480464 Ammonium Chloride affects the expression of COL4A2 mRNA CTD PMID:16483693 antimycin A increases expression ISO RGD:1317652 6480464 Antimycin A results in increased expression of COL4A2 mRNA CTD PMID:33512557 arsane affects methylation ISO RGD:1317652 6480464 Arsenic affects the methylation of COL4A2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1317652 6480464 Arsenic affects the methylation of COL4A2 gene CTD PMID:25304211 atrazine increases expression ISO RGD:1317652 6480464 Atrazine results in increased expression of COL4A2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of COL4A2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1317652 6480464 Benzo(a)pyrene affects the methylation of COL4A2 intron CTD PMID:30157460 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of COL4A2 mRNA CTD PMID:22610609 , PMID:32417428 benzo[a]pyrene increases expression ISO RGD:1317652 6480464 Benzo(a)pyrene results in increased expression of COL4A2 mRNA CTD PMID:20106945 , PMID:21632981 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of COL4A2 mRNA CTD PMID:26377693 benzo[e]pyrene decreases methylation ISO RGD:1317652 6480464 benzo(e)pyrene results in decreased methylation of COL4A2 intron CTD PMID:30157460 beta-carotene decreases expression ISO RGD:1317652 6480464 beta Carotene results in decreased expression of COL4A2 mRNA CTD PMID:17034753 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1317652 6480464 Diethylhexyl Phthalate results in increased expression of COL4A2 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1308085 6480464 bisphenol A results in decreased expression of COL4A2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1317652 6480464 bisphenol A results in increased expression of COL4A2 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1317652 6480464 bisphenol A results in decreased methylation of COL4A2 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of COL4A2 mRNA CTD PMID:29165653 more ... Bisphenol B increases expression ISO RGD:1317652 6480464 bisphenol B results in increased expression of COL4A2 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of COL4A2 mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of COL4A2 mRNA CTD PMID:30951980 C60 fullerene increases expression ISO RGD:1308085 6480464 fullerene C60 results in increased expression of COL4A2 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:1317652 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL4A2 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL4A2 mRNA CTD PMID:29741670 , PMID:35301059 cadmium dichloride decreases expression ISO RGD:1317652 6480464 Cadmium Chloride results in decreased expression of COL4A2 mRNA CTD PMID:12760830 cadmium dichloride multiple interactions ISO RGD:1317652 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL4A2 mRNA, [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL4A2 mRNA CTD PMID:29741670 , PMID:35301059 cadmium dichloride increases expression ISO RGD:1317652 6480464 Cadmium Chloride results in increased expression of COL4A2 mRNA CTD PMID:12160620 calcitriol decreases expression ISO RGD:1317652 6480464 Calcitriol results in decreased expression of COL4A2 mRNA CTD PMID:12875902 carbamazepine affects expression ISO RGD:1317652 6480464 Carbamazepine affects the expression of COL4A2 mRNA CTD PMID:25979313 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of COL4A2 protein CTD PMID:21135415 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of COL4A2 mRNA CTD PMID:33711761 chromium(6+) decreases expression ISO RGD:1317652 6480464 chromium hexavalent ion results in decreased expression of COL4A2 mRNA CTD PMID:30690063 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of COL4A2 mRNA CTD PMID:12771043 cisplatin multiple interactions ISO RGD:1317652 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of COL4A2 mRNA, [Cisplatin co-treated with Paclitaxel] results in decreased expression of COL4A2 mRNA CTD PMID:20705681 , PMID:27392435 cisplatin decreases expression ISO RGD:1317652 6480464 Cisplatin results in decreased expression of COL4A2 mRNA CTD PMID:27392435 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of COL4A2 mRNA CTD PMID:23625948 clobetasol decreases expression EXP 6480464 Clobetasol results in decreased expression of COL4A2 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:1317652 6480464 cobaltous chloride results in decreased expression of COL4A2 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1317652 6480464 [Chelating Agents binds to Copper] which results in decreased expression of COL4A2 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1317652 6480464 [Chelating Agents binds to Copper] which results in decreased expression of COL4A2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1317652 6480464 Copper Sulfate results in increased expression of COL4A2 mRNA CTD PMID:19549813 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL4A2 mRNA] CTD PMID:18200517 cyclosporin A decreases expression ISO RGD:1317652 6480464 Cyclosporine results in decreased expression of COL4A2 mRNA CTD PMID:20106945 , PMID:27989131 D-glucose affects secretion ISO RGD:1317652 6480464 Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 deguelin increases expression ISO RGD:1317652 6480464 deguelin results in increased expression of COL4A2 mRNA CTD PMID:33512557 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of COL4A2 mRNA CTD PMID:22733784 dextran sulfate decreases expression EXP 6480464 Dextran Sulfate results in decreased expression of COL4A2 protein CTD PMID:32272095 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A2 mRNA, Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL4A2 protein] CTD PMID:29950665 , PMID:32272095 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 dicrotophos increases expression ISO RGD:1317652 6480464 dicrotophos results in increased expression of COL4A2 mRNA CTD PMID:28302478 dimethylarsinous acid decreases expression ISO RGD:1317652 6480464 dimethylarsinous acid results in decreased expression of COL4A2 mRNA CTD PMID:23487506 dimethylselenide multiple interactions ISO RGD:1317652 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA, [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA CTD PMID:33656867 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A2 mRNA CTD PMID:30529165 diuron increases expression ISO RGD:1308085 6480464 Diuron results in increased expression of COL4A2 mRNA CTD PMID:21551480 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of COL4A2 mRNA CTD PMID:15033991 , PMID:29064158 doxorubicin decreases expression ISO RGD:1317652 6480464 Doxorubicin results in decreased expression of COL4A2 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 2 more ... CTD PMID:29064158 endosulfan decreases expression ISO RGD:1308085 6480464 Endosulfan results in decreased expression of COL4A2 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of COL4A2 mRNA CTD PMID:30319688 folpet decreases expression EXP 6480464 folpet results in decreased expression of COL4A2 mRNA CTD PMID:31558096 glucose affects secretion ISO RGD:1317652 6480464 Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 hydroxyl multiple interactions ISO RGD:1317652 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA CTD PMID:33656867 isotretinoin increases expression ISO RGD:1317652 6480464 Isotretinoin results in increased expression of COL4A2 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:1317652 6480464 Ivermectin results in decreased expression of COL4A2 protein CTD PMID:32959892 lead(0) decreases expression ISO RGD:1317652 6480464 Lead results in decreased expression of COL4A2 mRNA CTD PMID:19921347 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of COL4A2 mRNA CTD PMID:27339419 lipopolysaccharide multiple interactions ISO RGD:1317652 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of COL4A2 mRNA CTD PMID:35811015 methapyrilene decreases methylation ISO RGD:1317652 6480464 Methapyrilene results in decreased methylation of COL4A2 intron CTD PMID:30157460 methidathion increases expression EXP 6480464 methidathion results in increased expression of COL4A2 mRNA CTD PMID:34813904 methimazole increases expression ISO RGD:1308085 6480464 Methimazole results in increased expression of COL4A2 mRNA CTD PMID:30047161 mitomycin C affects response to substance ISO RGD:1317652 6480464 COL4A2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1308085 6480464 [Permethrin co-treated with DEET] results in increased methylation of COL4A2 gene CTD PMID:33148267 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of COL4A2 mRNA CTD PMID:12771043 N-nitrosodimethylamine increases expression ISO RGD:1308085 6480464 Dimethylnitrosamine results in increased expression of COL4A2 mRNA CTD PMID:25380136 nickel subsulfide decreases expression ISO RGD:1317652 6480464 nickel subsulfide results in decreased expression of COL4A2 mRNA CTD PMID:12760830 oxaliplatin increases expression ISO RGD:1308085 6480464 oxaliplatin results in increased expression of COL4A2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:1308085 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL4A2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1317652 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA CTD PMID:33656867 paclitaxel multiple interactions ISO RGD:1317652 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of COL4A2 mRNA CTD PMID:20705681 paclitaxel increases expression ISO RGD:1317652 6480464 Paclitaxel results in increased expression of COL4A2 mRNA CTD PMID:19682730 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of COL4A2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1317652 6480464 Acetaminophen results in increased expression of COL4A2 mRNA CTD PMID:29067470 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of COL4A2 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL4A2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1308085 6480464 perfluorooctanoic acid results in increased expression of COL4A2 mRNA CTD PMID:28511854 permethrin multiple interactions ISO RGD:1308085 6480464 [Permethrin co-treated with DEET] results in increased methylation of COL4A2 gene CTD PMID:33148267 phenethyl isothiocyanate decreases expression ISO RGD:1308085 6480464 phenethyl isothiocyanate results in decreased expression of COL4A2 mRNA CTD PMID:17616710 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of COL4A2 mRNA CTD PMID:23811191 potassium chromate decreases expression ISO RGD:1317652 6480464 potassium chromate(VI) results in decreased expression of COL4A2 mRNA CTD PMID:22714537 rotenone decreases expression ISO RGD:1317652 6480464 Rotenone results in decreased expression of COL4A2 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1317652 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of COL4A2 mRNA CTD PMID:35811015 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of COL4A2 mRNA CTD PMID:29203145 silver atom increases expression ISO RGD:1317652 6480464 Silver results in increased expression of COL4A2 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1317652 6480464 Silver results in increased expression of COL4A2 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO RGD:1317652 6480464 sodium arsenite results in decreased expression of COL4A2 mRNA CTD PMID:22714537 sodium dichromate decreases expression ISO RGD:1317652 6480464 sodium bichromate results in decreased expression of COL4A2 mRNA CTD PMID:12760830 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of COL4A2 mRNA CTD PMID:30642005 streptozocin multiple interactions EXP 6480464 MIR29A mRNA inhibits the reaction [Streptozocin results in increased expression of COL4A2 mRNA] CTD PMID:30642005 sulfadimethoxine increases expression ISO RGD:1308085 6480464 Sulfadimethoxine results in increased expression of COL4A2 mRNA CTD PMID:30047161 temozolomide increases expression ISO RGD:1317652 6480464 Temozolomide results in increased expression of COL4A2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1317652 6480464 tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA CTD PMID:15336504 testosterone enanthate affects expression ISO RGD:1317652 6480464 testosterone enanthate affects the expression of COL4A2 mRNA CTD PMID:17440010 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of COL4A2 mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide increases expression ISO RGD:1308085 6480464 Thioacetamide results in increased expression of COL4A2 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of COL4A2 mRNA CTD PMID:27760801 , PMID:29264374 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A2 mRNA CTD PMID:29950665 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of COL4A2 mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:1308085 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of COL4A2 mRNA CTD PMID:25729387 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of COL4A2 mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of COL4A2 mRNA CTD PMID:28973697 valproic acid increases methylation ISO RGD:1317652 6480464 Valproic Acid results in increased methylation of COL4A2 gene CTD PMID:29154799 valproic acid affects splicing ISO RGD:1308085 6480464 Valproic Acid affects the splicing of COL4A2 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1308085 6480464 Valproic Acid results in decreased expression of COL4A2 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1317652 6480464 Valproic Acid results in decreased expression of COL4A2 mRNA CTD PMID:28001369 , PMID:29154799 vancomycin decreases expression EXP 6480464 Vancomycin results in decreased expression of COL4A2 mRNA CTD PMID:18930951 vinclozolin increases expression ISO RGD:1308085 6480464 vinclozolin results in increased expression of COL4A2 mRNA CTD PMID:23034163